A detailed history of Pictet Asset Management Sa transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 12,415 shares of AUPH stock, worth $100,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,415
Previous 12,415 -0.0%
Holding current value
$100,809
Previous $136,000 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$5.94 - $11.27 $38,372 - $72,804
-6,460 Reduced 34.23%
12,415 $136,000
Q4 2022

Feb 13, 2023

BUY
$4.11 - $8.14 $77,576 - $153,642
18,875 New
18,875 $82,000
Q1 2022

May 13, 2022

SELL
$10.05 - $22.48 $14.6 Million - $32.6 Million
-1,449,624 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$17.78 - $33.08 $7.7 Million - $14.3 Million
433,205 Added 42.62%
1,449,624 $33.2 Million
Q3 2021

Nov 12, 2021

BUY
$10.93 - $23.55 $11.1 Million - $23.9 Million
1,016,419 New
1,016,419 $22.5 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.